Welcome To The Mannkind HUB On AGORACOM

Edit this title from the Fast Facts Section

Free
Message: Lilly bets on new insulin products with $180M plant addition

Interesting....they are scaling up on plants while losing patent protection and cutting sales reps. I know for a fact...I just hired one of Eli Lilly's high performers for one of my open positions...largely based on the conerns they were scaling back and choosing not to extend a few current programs. Maybe preparing for something else?

Share
New Message
Please login to post a reply